GSK and Prosensa Will Hold a Joint Webinar on October 15

GSK and Prosensa will hold a joint webinar on 15th October at 16:00 – 17:30 GMT (17:00 – 18:30 CET, 12:00 – 13:30 EST, 09:00 – 10:30 PST).

Following on from the disappointing results of the phase III DMD114044 study which did not meet its primary or key secondary endpoints, GSK will share the pivotal study results which were presented at the recent World Muscle Society annual international congress and hold a live Q&A session.

In the second part of the webinar, Prosensa will discuss its other Duchenne programs and will also take live questions during the Q&A session.